今夜！A股突发！

Core Viewpoint - Multiple stocks in the commercial aerospace and brain-computer interface sectors have issued announcements regarding abnormal trading activities, indicating potential risks and the need for investor caution [2]. Group 1: Commercial Aerospace Stocks - Beidou Xingtong announced that its stock price had deviated significantly, with a cumulative increase of over 20% in three consecutive trading days, and emphasized that commercial aerospace is just one of its application scenarios [2]. - Aerospace Hanyu expects that by 2025, revenue from commercial aerospace will account for less than 15% of its total revenue, indicating limited reliance on this sector [4][5]. - China Satellite reported a cumulative stock price increase of 156.07% since December 3, 2025, significantly outpacing the industry and market indices, suggesting a potential for irrational market behavior [15]. Group 2: Brain-Computer Interface Stocks - Aerospace Changfeng clarified that it does not engage in brain-computer interface or commercial aerospace businesses, despite being categorized as such by the market [9]. - Sanbo Neuroscience stated that it currently does not involve in the research, production, or sales of brain-computer interface products, and the revenue from related technologies is minimal [12]. - Xiangyu Medical focuses on non-invasive brain-computer interface technology but has not achieved large-scale sales as of the end of 2025, indicating a nascent stage in this area [18]. Group 3: Stock Trading Risks - China Satellite highlighted the "hot potato" effect in its stock trading, indicating a high risk of price correction due to speculative trading [8]. - Guosheng Technology announced a trading suspension due to a cumulative price increase of 370.20%, which deviated from its fundamentals, indicating a high risk of rapid price decline [24]. - Jia Mei Packaging will suspend trading for up to three days starting January 7, 2026, due to a 230.48% price increase that diverged from its fundamental value [26].